Hong Kai Teo

Hong Kai Teo is currently a PhD graduate student at the National University of Singapore, focusing on the development of screening targets for neoantigen cancer vaccines for colorectal cancer and hepatocellular carcinoma patients. With experience as a pharmacist and pre-registration pharmacist at the National Cancer Centre Singapore and Changi General Hospital, Hong provides counseling and medication management for cancer patients. Previous roles include a regional pharmacovigilance intern and medical affairs intern at Bayer, pharmacy intern at Unity by Fairprice, and researcher at various institutions including the University of Nottingham and A*STAR. Hong has a Bachelor of Pharmacy degree from the National University of Singapore and is pursuing a PhD in Immunotherapy and Pharmaceutical Science.